Presenter: Gonçalo Regalo, Sr. Product Manager CGT, FUJIFILM Biosciences

What determines whether a cell therapy can successfully move from early research into robust, scalable manufacturing processes?  

In this Cell & Gene Tech Expo Presentation, Gonçalo Regalo, Sr. Product Manager CGT, FUJIFILM Biosciences, discusses how process outcomes are strongly influenced by decisions made during early development, particularly in the selection and qualification of raw materials, media formulations, and processing strategies. 

Watch a recording of this session from the Cell & Gene Tech Expo to gain expert insights on:

• Identifying how early raw material and media formulation decisions influence critical quality attributes and process robustness
• Understanding how raw material qualification strategies evolve from early development through clinical and commercial manufacturing
• Evaluating approaches for managing variability in patient-derived starting material
• Assessing scalable and modular process design strategies for cell therapy manufacturing
• Determining which process steps are most critical for automation to improve reproducibility, efficiency, and GMP readiness